Our observation that CMS2, CMS3 and CMS4 enrichment in the Myc gene sets Myc targets V1 and Myc targets V2 suggests that key cell signaling and metabolic pathways within tumor cells driving tumor growth and progression are differentially regulated by obesity. Here, MYC is linked to obesity due to melanocortin 4 receptor deficiency.